Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,590.00
-140.00 (-2.08%)
Last updated: Mar 24, 2025
-33.53%
Market Cap 55.51B
Revenue (ttm) 75.41B
Net Income (ttm) 2.91B
Shares Out 8.44M
EPS (ttm) 334.08
PE Ratio 19.70
Forward PE n/a
Dividend 95.40 (1.45%)
Ex-Dividend Date Dec 27, 2024
Volume 18,772
Average Volume 50,137
Open 6,730.00
Previous Close 6,730.00
Day's Range 6,570.00 - 6,780.00
52-Week Range 5,988.04 - 11,429.00
Beta 0.76
RSI 42.18
Earnings Date Mar 18, 2025

About Seoulin Bioscience

Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd. was founded in 1984 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1984
Employees 104
Stock Exchange KOSDAQ
Ticker Symbol 038070
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.